15 Analysts Assess Axsome Therapeutics: What You Need To Know
15 Analysts Assess Axsome Therapeutics: What You Need To Know
15位分析師評估axsome therapeutics：需要知道的一切
Throughout the last three months, 15 analysts have evaluated Axsome Therapeutics (NASDAQ:AXSM), offering a diverse set of opinions from bullish to bearish.
在過去的三個月中，15名分析師對axsome therapeutics（納斯達克:AXSM）進行了評估，提供了從看好到看淡的多樣化意見。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格總結了分析師們最近的評級，揭示了過去30天內情緒的變化並將其與前幾個月進行了比較。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $137.8, a high estimate of $190.00, and a low estimate of $106.00. Witnessing a positive shift, the current average has risen by 7.07% from the previous average price target of $128.70.
分析師通過他們對12個月價格目標的評估提供更深入的見解，揭示了一個平均目標價格爲137.8美元，最高預估爲190美元，最低爲106美元。目前的平均價格較上一個平均價格目標128.7美元上漲了7.07%。
Breaking Down Analyst Ratings: A Detailed Examination
分析師評級分析：詳細分析
An in-depth analysis of...
對最近分析...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。